CD47 and cancer: Therefore, further Pearson analysis was conducted to investigate the correlation between GPR65 and common cancer immune checkpoint inhibitors, such as CD200R1, CD47, HAVCR2, TIGIT, CTLA4, LAG3, and PD1.